Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors

Publication Date: March 28, 2018

Last Updated: March 14, 2022

Recommendations

Which new genes should be tested for lung cancer patients?

ROS1 testing must be performed on all lung adenocarcinoma patients, irrespective of clinical characteristics. (S)

324662

Overview

Title

Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors

Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors

Recommendations

Which new genes should be tested for lung cancer patients?

Overview

Title

Authoring Organizations